河北医科大学学报

• 论著 • 上一篇    下一篇

羟苯磺酸钙对妥布霉素肾毒性的保护作用#br#

  

  1. 河北省胸科医院呼吸三科,河北 石家庄 050041
  • 出版日期:2018-05-25 发布日期:2018-05-30
  • 作者简介:李艳君(1975-),女,河北保定人,河北省胸科医院主治医师,医学学士,从事呼吸系统疾病诊治研究。

Protective effect of calcium  dobesilate on tobramycininduced nephrotoxicity in rats#br#

  1. Department of Respiration, Hebei Chest Hospital, Shijiazhuang 050041, China
  • Online:2018-05-25 Published:2018-05-30

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗探讨羟苯磺酸钙对妥布霉素诱导的肾毒性的保护作用。
〖HTH〗方法〖HTSS〗〖KG*2〗 30只雄性SD大鼠随机分为3组。对照组腹腔注射生理盐水3 mL·kg-1·d-1;模型组腹腔注射妥布霉素140 mg·kg-1·d-1;预防组腹腔注射妥布霉素140 mg·kg-1·d-1加羟苯磺酸钙100 mg/kg。3组均干预7 d。测定3组尿N乙酰D氨基葡萄糖苷(NacetylβDglucosaminidase,NAG)、血清肌酐(serum creatinine,SCr)和尿素氮(blood usea nitrogen,BUN)水平,并测量肾组织中超氧化物歧化酶(superoxide dismutase,SOD)和丙二醛(malondialdehyde,MDA)以评估肾组织样品中的氧化应激水平。
〖HTH〗结果〖HTSS〗〖KG*2〗模型组和预防组大鼠尿NAG、SCr、BUN水平显著高于对照组,肾皮质匀浆中SOD水平显著降于对照组,MDA水平显著高于对照组(P<0.05);预防组大鼠尿NAG、SCr、BUN水平显著低于模型组,肾皮质匀浆中SOD水平显著高于模型组,MDA水平显著低于模型组(P<005)。
〖HTH〗结论〖HTSS〗〖KG*2〗羟苯磺酸钙对妥布霉素诱导的肾毒性有预防保护作用。

关键词: 肾疾病, 妥布霉素, 羟苯磺酸钙

Abstract: [Abstract]〓Objective〖HTSS〗〓To investigate the protective effect of calcium dobesilate on tobramycininduced nephrotoxicity.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓Thirty male SpragueDawley rats were randomly divided into three groups. The control group were injected with the normal saline(3 mL·kg-1·d-1)for 7 d. The model were injected with tobramycin(140 mg·kg-1·d-1) for 7 d. The prevention group were injected with tobramycin(140 mg·kg-1·d-1) plus received calcium dobesilate(100 mg·kg-1·d-1) for 7 d. NacetylβDglucosaminidase(NAG), serum creatinine(SCr) and blood urea nitrogen(BUN)concentrations were monitored. Superoxide dismutase(SOD) and malondialdehyde(MDA) were measured to assess the level of oxidative stress in renal tissue samples.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓The urinary NAG, SCr, BUN and MDA levels were significantly higher in the model group and the prevention group than that in the control group,and the SOD level of the renal cortex homogenate was significantly lower than that in the control group(P<0.05). The urinary NAG, SCr, BUN and MDA levels were significantly lower in the prevention group than that in the model group, and the level of SOD of the renal cortex homogenate was significantly higher than in the model group(P<005).
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Calcium dobesilate is capable of protecting rats against tobramycininduced nephrotoxicity.

Key words: kidney diseases, tobramycin, calcium dobesilate